ATC code C08

ATC codes
C Cardiovascular system
C01 Cardiac therapy
C02 Antihypertensives
C03 Diuretics
C04 Peripheral vasodilators
C05 Vasoprotectives
C07 Beta blocking agents
C08 Calcium channel blockers
C09 Agents acting on the renin–angiotensin system
C10 Lipid modifying agents
A B C D G H QI J L M N P R S V (Hover over links to see titles)

ATC code C08 Calcium channel blockers is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>

ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.

</ref><ref>

ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.

</ref> Subgroup C08 is part of the anatomical group C Cardiovascular system.<ref>

ATC/DDD Index 2022

code C08(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC08.<ref>

ATCvet Index 2022

code QC08(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

C08C Selective calcium channel blockers with mainly vascular effects

C08CA Dihydropyridine derivatives

C08CA01 Amlodipine

C08CA02 Felodipine

C08CA03 Isradipine

C08CA04 Nicardipine

C08CA05 Nifedipine

C08CA06 Nimodipine

C08CA07 Nisoldipine

C08CA08 Nitrendipine

C08CA09 Lacidipine

C08CA10 Nilvadipine

C08CA11 Manidipine

C08CA12 Barnidipine

C08CA13 Lercanidipine

C08CA14 Cilnidipine

C08CA15 Benidipine

C08CA16 Clevidipine

C08CA55 Nifedipine, combinations

C08CX Other selective calcium channel blockers with mainly vascular effects

C08CX01 Mibefradil

C08D Selective calcium channel blockers with direct cardiac effects

C08DA Phenylalkylamine derivatives

C08DA01 Verapamil

C08DA02 Gallopamil

C08DA51 Verapamil, combinations

C08DB Benzothiazepine derivatives

C08DB01 Diltiazem

C08E Non-selective calcium channel blockers

C08EA Phenylalkylamine derivatives

C08EA01 Fendiline

C08EA02 Bepridil

C08EX Other non-selective calcium channel blockers

C08EX01 Lidoflazine

C08EX02 Perhexiline

C08G Calcium channel blockers and diuretics

C08GA Calcium channel blockers and diuretics

C08GA01 Nifedipine and diuretics

C08GA02 Amlodipine and diuretics